Regenerative medicine: Basic concepts, current status, and future applications

Journal of Investigative Medicine

Volumn 58, Issue 7, 2010, Pages 849-858

  Corona, Benjamin T ^a   Ward, Catherine L ^a   Harrison, Benjamin S ^a   Christ, George J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Biomaterials; Bladder; Regenerative medicine; Scaffolds; Skeletal muscle; Tissue engineering

Indexed keywords

BIOMATERIAL; OXYGEN;

BIOREACTOR; BLADDER RECONSTRUCTION; CELL EXPANSION; CELL REGENERATION; CONFERENCE PAPER; ELECTROSPINNING; FUTUROLOGY; HUMAN; IMPLANTATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MENINGOMYELOCELE; NONHUMAN; REGENERATIVE MEDICINE; SKELETAL MUSCLE; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; ARTICLE; BIOPRINTING; BLADDER; IN VIVO STUDY; MUSCLE REGENERATION; STEM CELL;

EID: 85008249027     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/jim.0b013e3181efbc61     Document Type: Conference Paper

References (98)

1. Stocum DL. Regenerative biology and medicine. J Musculoskelet Neuronal Interact. 2002;2:270-273.
2. Atala A. Recent applications of regenerative medicine to urologic structures and related tissues. Curr Opin Urol. 2006;16:305-309.
3. MacNeil S. Progress and opportunities for tissue-engineered skin. Nature. 2007;445:874-880.
4. Mikos AG, Herring SW, Ochareon P, et al. Engineering complex tissues. Tissue Eng. 2006;12:3307-3339.
5. Nerem RM. Tissue engineering: the hope, the hype, and the future. Tissue Eng. 2006;12:1143-1150.
6. Vacanti CA. The history of tissue engineering. J Cell Mol Med. 2006;10:569-576.
7. Vacanti JP. Editorial: tissue engineering: a 20-year personal perspective. Tissue Eng. 2007;13:231-232.
8. Ehnert S, Glanemann M, Schmitt A, et al. The possible use of stem cells in regenerative medicine: dream or reality? Langenbecks Arch Surg. 2009;394:985-997.
9. Ratajczak MZ, Zuba-Surma EK, Wysoczynski M, et al. Hunt for pluripotent stem cell-regenerative medicine search for almighty cell. J Autoimmun. 2008;30:151-162.
10. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells. 2001;19:193-204.
11. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
12. Hong SJ, Traktuev DO, March KL. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Curr Opin Organ Transplant. 2010;15:86-91.
13. Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng. 2010;12:87-117.
14. Markert CD, Atala A, Cann JK, et al. Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy. PM R. 2009;1:547-559.
15. Alhadlaq A, Mao JJ. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 004; 13:436-448.
16. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213:341-347.
17. Krebsbach PH, Kuznetsov SA, Satomura K, et al. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation. 1997;63:1059-1069. (Pubitemid 27190967)
18. Okada S, Nagayoshi K, Nakauchi H, et al. Sequential analysis of hematopoietic reconstitution achieved by transplantation of hematopoietic stem cells. Blood. 1993;81:1720-1725.
19. Gates CB, Karthikeyan T, Fu F, et al. Regenerative medicine for the musculoskeletal system based on muscle-derived stem cells. J Am Acad Orthop Surg. 2008;16:68-76.
20. Jiang Y, Vaessen B, Lenvik T, et al. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol. 2002;30:896904.
21. Presnell SC, Petersen B, Heidaran M. Stem cells in adult tissues. Semin Cell Dev Biol. 2002;13:369-376.
22. Zammit P, Beauchamp J. The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation. 2001;68:193-204.
23. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 1961;9:493-495.
24. Rathbone CR, Wenke JC, Warren GL, et al. Importance of satellite cells in the strength recovery after eccentric contraction-induced muscle injury. Am J Physiol Regul Integr Comp Physiol. 2003;285: R1490-R1495.
25. Tedesco FS, Dellavalle A, Diaz-Manera J, et al. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest. 2010;120:11-19.
26. Da Sacco S, Sedrakyan S, Boldrin F, et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol. 2010;183:1193-1200.
27. De Coppi P, Callegari A, Chiavegato A, et al. Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol. 2007;177:369-376.
28. Maherali N, Ahfeldt T, Rigamonti A, et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell. 2008;3:340-345.
29. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676.
30. Wernig, M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448:318-324. (Pubitemid 47080337)
31. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917-1920.
32. Lengner CJ. iPS cell technology in regenerative medicine. Ann N Y Acad Sci. 2010;192:38-44.
33. Noguchi H. Production of pancreatic beta-cells from stem cells. Curr Diabetes Rev. 2010;6:184-190.
34. Wernig M, Zhao JP, Pruszak J, et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fet al. brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A. 2008;05:5856-5861.
35. Yokoo T, Kawamura T, Kobayashi E. Kidney organogenesis and regeneration: a new era in the treatment of chronic renal failure? Clin Exp Nephrol. 2008;12:326-331.
36. Chung NG, Jeong DC, Park SJ, et al. Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int J Hematol. 2004;80:370-376.
37. Madec AM, Mallone R, Afonso G, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia. 2009;52:1391-1399.
38. Nagaya N, Fujii T, Iwase T, et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004;287: H2670-H2676.
39. Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009;106:14022-14027.
40. Vija L, Farge D, Gautier JF, et al. Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes Metab. 2009;35:85-93.
41. Shabbir A, Zisa D, Leiker M, et al. Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammation. Transplantation. 2009;87:1275-1282.
42. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30:42-48.
43. Cao Y, Sun Z, Liao L, et al. Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun. 2005;332:370-379.
44. Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102:3837-3844.
45. Pozzobon M, Ghionzoli M, De Coppi P. ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective. Pediatr Surg Int. 2010;26:3-10.
46. Williams DF. On the nature of biomaterials. Biomaterials. 2009;30:5897-5909.
47. Coutu DL, Yousefi AM, Galipeau J. Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy. J Cell Biochem. 2009;108:537-546.
48. Dutta RC, Dutta AK. Cell-interactive 3D-scaffold; advances and applications. Biotechnol Adv. 2009;27:334-339.
49. Facca S, Gillet P, Stoltz JF, et al. Three-dimensional sprayed active biological gels and cells for tissue engineering application. Biomed Mater Eng. 2008;18:231-235.
50. Zhang K, Mo X, Huang C, et al. Electrospun scaffolds from silk fibroin and their cellular compatibility. J Biomed Mater Res A. 2010;93:976-983.
51. Zhu Y, Cao Y, Pan J, et al. Macro-alignment of electrospun fibers for vascular tissue engineering. J Biomed Mater Res B Appl Biomater. 2010;92:508-516.
52. Zuo Y, Yang F, Wolke JG, et al. Incorporation of biodegradable electrospun fibers into calcium phosphate cement for bone regeneration. Acta Biomater. 2010;6:1238-1247.
53. Ju YM, Choi JS, Atala A, et al. Bilayered scaffold for engineering cellularized blood vessels. Biomaterials. 2010;31:4313-4321.
54. Choi JS, Lee SJ, Christ GJ, et al. The influence of electrospun aligned poly (epsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials. 2008;29:2899-2906.
55. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23:879-884.
56. Pandit AS, Wilson DJ, Feldman DS. Fibrin scaffold as an effective vehicle for the delivery of acidic fibroblast growth factor (FGF-1). J Biomater Appl. 2000;14:229-242.
57. Centis V, Vermette P. Enhancing oxygen solubility using hemoglobin-and perfluorocarbon-based carriers. Front Biosci. 2009;14:665-688.
58. Harrison BS, Eberli D, Lee SJ, et al. Oxygen producing biomaterials for tissue regeneration. Biomaterials. 2007;28:4628-4634.
59. Oh SH, Ward CL, Atala A, et al. Oxygen generating scaffolds for enhancing engineered tissue survival. Biomaterials. 2009;30:757-762.
60. Cooper GM, Miller ED, Decesare GE, et al. Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation. Tissue Eng Part A. 2010;16:1749-1759.
61. Mironov V, Kasyanov V, Drake C, et al. Organ printing: promises and challenges. Regen Med. 2008;3:93-103.
62. Mironov V, Visconti RP, Kasyanov V, et al. Organ printing: tissue spheroids as building blocks. Biomaterials. 2009;30:2164-2174.
63. Moon S, Hasan SK, Song YS, et al. Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng Part C Methods. 2010;16:157-166.
64. Visconti RP, Kasyanov V, Gentile C, et al. Towards organ printing: engineering an intra-organ branched vascular tree. Expert Opin Biol Ther. 2010;10:409-420.
65. Varghese D, Deshpande M, Xu T, et al. Advances in tissue engineering: cell printing. J Thorac Cardiovasc Surg. 2005;129:470-472.
66. Boland T, Xu T, Damon B, et al. Application of inkjet printing to tissue engineering. Biotechnol J. 2006;1:910-917.
67. Xu T, Jin J, Gregory C, et al. Inkjet printing of viable mammalian cells. Biomaterials. 2005;26:93-99.
68. Khan MS, Fon D, Li X, et al. Biosurface engineering through ink jet printing. Colloids Surf B Biointerfaces. 2010;75:441-447.
69. Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367:1241-1246.
70. Atala A. Bioengineered tissues for urogenital repair in children. Pediatr Res. 2008;63:569-575.
71. Sanchez Alvarado A, Tsonis PA. Bridging the regeneration gap: genetic insights from diverse animal models. Nat Rev Genet. 2006;7:873-884.
72. Roy S, Gatien S. Regeneration in axolotls: a model to aim for! Exp Gerontol. 2008;43:968-973.
73. Tsonis PA. Bridging knowledge gaps on the long road to regeneration: classical models meet stem cell manipulation and bioengineering. Mol Interv. 2007;7:249-250.
74. Schwartz R. Ricerche in proposito della rigenerazione della cescica urinaria. Sperimentale. 1891;45:484.
75. Jayo MJ, Jain D, Wagner BJ, et al. Early cellular and stromal responses in regeneration versus repair of a mammalian bladder using autologous cell and biodegradable scaffold technologies. J Urol. 2008;180:392-397.
76. Oberpenning F, Meng J, Yoo JJ, et al. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol. 1999;17:149-155.
77. Liang DS. Secondary cystectomy in rats. J Urol. 1963;90:187-188.
78. Liang DS, Goss RJ. Regeneration of the bladder after subtotal cystectomy in rats. J Urol. 1963;89:427-430.
79. Sisk V, Neu I. Regeneration of the bladder: a case study. Trans Am Assoc Genito-urin Surg. 1939;32:197.
80. Bohne AW, Urwiller KL. Experience with urinary bladder regeneration. J Urol. 1957;77:725-732.
81. Aboushwareb T, Zhou G, Deng FM, et al. Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol Urodyn. 2009;28:1028-1033.
82. Burmeister D, Aboushwareb T, Tan J, et al. Early stages of in situ bladder regeneration in a rodent model. Tissue Eng Part A. 2010; May 18. [Epub ahead of print].
83. Christ GJ, Day NS, Day M, et al. Bladder injection of "naked" hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. Am J Physiol Regul Integr Comp Physiol. 2001;281: R1699-1709.
84. Woodman SE, Cheung MW, Tarr M, et al. Urogenital alterations in aged male caveolin-1 knockout mice. J Urol. 2004;171:950-957.
85. Moon du G, Christ G, Stitzel JD, et al. Cyclic mechanical preconditioning improves engineered muscle contraction. Tissue Eng Part A. 2008;14:473-482.
86. Borschel GH, Dennis RG, Kuzon WM Jr. Contractile skeletal muscle tissue-engineered on an acellular scaffold. Plast Reconstr Surg. 2004;113:595-602; discussion 594-603.
87. Borschel GH, Dow DE, Dennis RG, et al. Tissue-engineered axially vascularized contractile skeletal muscle. Plast Reconstr Surg. 2006;117:2235-2242.
88. Donnelly K, Khodabukus A, Philp A, et al. A novel bioreactor for stimulating skeletal muscle in vitro. Tissue Eng Part C Methods. 2010. [Epub ahead of print].
89. Huang YC, Dennis RG, Larkin L, et al. Rapid formation of functional muscle in vitro using fibrin gels. J Appl Physiol. 2005;98:706-713.
90. Abousleiman RI, Sikavitsas VI. Bioreactors for tissues of the musculoskeletal system. Adv Exp Med Biol. 2006;585:243-259.
91. Khodabukus A, Paxton JZ, Donnelly K, et al. Engineered muscle: a tool for studying muscle physiology and function. Exerc Sport Sci Rev. 2007;35:186-191.
92. Vandenburgh H. High-content drug screening with engineered musculoskeletal tissues. Tissue Eng Part B Rev. 2010;16:55-64.
93. Vandenburgh H, Shansky J, Benesch-Lee F, et al. Drug-screening platform based on the contractility of tissue-engineered muscle. Muscle Nerve. 2008;37:438-447.
94. Vandenburgh H, Shansky J, Benesch-Lee F, et al. Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts. FASEB J. 2009;23:3325-3334.
95. Machingal MA, Corona BT, Kesireddy V, et al. Bioengineered skeletal muscle for defect replacement in a rodent model. FASEB J. 2010;24:842-843.
96. Larkin LM, Van der Meulen JH, Dennis RG, et al. Functional evaluation of nerve-skeletal muscle constructs engineered in vitro. In Vitro Cell Dev Biol Anim. 2006;42:75-82.
97. Merritt EK, Hammers DW, Tierney M, et al. Functional assessment of skeletal muscle regeneration utilizing homologous extracellular matrix as scaffolding. Tissue Eng Part A. 2010;16:1395-1405.
98. Merritt EK, Cannon MV, Hammers DW, et al. Repair of traumatic skeletal muscle injury with bone marrow derived mesenchymal stem cells seeded on extracellular matrix. Tissue Eng Part A. 2010. [Epub ahead of print].